Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 18: Morgendlicher Blutdruckanstieg Abb. 19: Telmisartan - Perindopril Abb. 20: Telmisartan - Perindopril Aktuelles Bild - Abb. 21: Telmisartan - Enalapril Abb. 22: Telmisartan - Amlodipin Abb. 23: Telmisartan - Amlodipin Abb. 24: Blutdrucksenkung - Nephropathie Zum letzten Bild
Abbildung 21: Telmisartan - Enalapril
The efficacy of telmisartan at doses of 40 mg and 80 mg was compared with that of enalapril 20 mg in a 12-week multicentre, randomized, parallel-group, placebo-controlled study that included 440 patients with mild-to-moderate hypertension.1 The reduction in blood pressure with telmisartan was greater than with enalapril and reached statistical significance for the telmisartan 80 mg arm. Maximal blood pressure reductions were apparent by week 4 and were maintained through to week 12. 1. Smith DHG, et al. Once-daily telmisartan compared with enalapril in the treatment of hypertension. Adv Ther 1998; 15: 229–240.
 
Telmisartan - Enalapril
Vorheriges Bild Nächstes Bild   


Abbildung 21: Telmisartan - Enalapril
The efficacy of telmisartan at doses of 40 mg and 80 mg was compared with that of enalapril 20 mg in a 12-week multicentre, randomized, parallel-group, placebo-controlled study that included 440 patients with mild-to-moderate hypertension.1 The reduction in blood pressure with telmisartan was greater than with enalapril and reached statistical significance for the telmisartan 80 mg arm. Maximal blood pressure reductions were apparent by week 4 and were maintained through to week 12. 1. Smith DHG, et al. Once-daily telmisartan compared with enalapril in the treatment of hypertension. Adv Ther 1998; 15: 229–240.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung